Selected article for: "activity mechanism and exact mechanism"
Author: Del Re, Alessandro; Corpetti, Chiara; Pesce, Marcella; Seguella, Luisa; Steardo, Luca; Palenca, Irene; Rurgo, Sara; De Conno, Barbara; Sarnelli, Giovanni; Esposito, Giuseppe
Title: Ultramicronized Palmitoylethanolamide Inhibits NLRP3 Inflammasome Expression and Pro-Inflammatory Response Activated by SARS-CoV-2 Spike Protein in Cultured Murine Alveolar Macrophages
  • Cord-id: 7i0pcjsu
  • Document date: 2021_9_2
    • ID: 7i0pcjsu
    Snippet: Despite its possible therapeutic potential against COVID-19, the exact mechanism(s) by which palmitoylethanolamide (PEA) exerts its beneficial activity is still unclear. PEA has demonstrated analgesic, anti-allergic, and anti-inflammatory activities. Most of the anti-inflammatory properties of PEA arise from its ability to antagonize nuclear factor-κB (NF-κB) signalling pathway via the selective activation of the PPARα receptors. Acting at this site, PEA can downstream several genes involved
    Document: Despite its possible therapeutic potential against COVID-19, the exact mechanism(s) by which palmitoylethanolamide (PEA) exerts its beneficial activity is still unclear. PEA has demonstrated analgesic, anti-allergic, and anti-inflammatory activities. Most of the anti-inflammatory properties of PEA arise from its ability to antagonize nuclear factor-κB (NF-κB) signalling pathway via the selective activation of the PPARα receptors. Acting at this site, PEA can downstream several genes involved in the inflammatory response, including cytokines (TNF-α, Il-1β) and other signal mediators, such as inducible nitric oxide synthase (iNOS) and COX2. To shed light on this, we tested the anti-inflammatory and immunomodulatory activity of ultramicronized(um)-PEA, both alone and in the presence of specific peroxisome proliferator-activated receptor alpha (PPAR-α) antagonist MK886, in primary cultures of murine alveolar macrophages exposed to SARS-CoV-2 spike glycoprotein (SP). SP challenge caused a significant concentration-dependent increase in proinflammatory markers (TLR4, p-p38 MAPK, NF-κB) paralleled to a marked upregulation of inflammasome-dependent inflammatory pathways (NLRP3, Caspase-1) with IL-6, IL-1β, TNF-α over-release, compared to vehicle group. We also observed a significant concentration-dependent increase in angiotensin-converting enzyme-2 (ACE-2) following SP challenge. um-PEA concentration-dependently reduced all the analyzed proinflammatory markers fostering a parallel downregulation of ACE-2. Our data show for the first time that um-PEA, via PPAR-α, markedly inhibits the SP induced NLRP3 signalling pathway outlining a novel mechanism of action of this lipid against COVID-19.

    Search related documents:
    Co phrase search for related documents
    • absence presence and active role play: 1
    • absence presence and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • absence presence and low release: 1
    • absence presence and lung capacity: 1
    • accordingly treat and acute ards respiratory distress syndrome: 1
    • ace overexpression and acute ards respiratory distress syndrome: 1
    • activation cascade and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • activation marker and acute ards respiratory distress syndrome: 1, 2
    • active role and acute ards respiratory distress syndrome: 1, 2, 3, 4
    • active role and low release: 1
    • active role play and acute ards respiratory distress syndrome: 1
    • acute ards respiratory distress syndrome and add therapy: 1
    • acute ards respiratory distress syndrome and low release: 1, 2